NCT06072430 - A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Septic ShockSepsisHypovolemia

Interventions

DRUG

VBI-S

VBI-S is made of small particles of specific lipids called micelles and liposomes for the treatment of hypotension.

Trial Locations (6)

RECRUITING

Novant Healthcare, Winston-Salem

RECRUITING

Memorial Health University Medical Center, Savannah

RECRUITING

University Health, Kansas City

WITHDRAWN

Bryan Medical Center, Lincoln

RECRUITING

Dignity Health Chandler Regional Medical Center, Chandler

RECRUITING

Oregon Health & Science University (OHSU), Portland